Medical technology manufacturer plans to divest diabetes products business / Focus on injection systems © 2001-2024 Plasteurope.com | Imprint | Privacy | Cookie settings ...

Overview: Vivendi SE is a global entertainment, media, and communication company with operations across Europe, the Americas, Asia/Oceania, and Africa, and has a market cap of approximately €8.90 ...

Switzerland is scrambling to keep a lid on immigration from its top trade partner, the European Union, as a jobs boom powered ...

Switzerland is scrambling to keep a lid on immigration from its top trade partner, the European Union, as a jobs boom powered ...

Advancements in medical technology and increasing awareness about diabetes and blood testing drive innovation and adoption in the lancet industry.

The latest health news highlights FDA's approval of BridgeBio's drug for a rare heart condition, cancer features in healthy ...

Generating thousands of dollars of recurring income can be a great way to make you less reliant on employment income or ...

Investors have gotten a lot more mileage out of On Holding’s stock this year than Nike That might not change soon. Both On Holdings and Nike were on the receiving end of positive reports beginning ...

Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.

Novo Nordisk's (NVO) contract Ypsomed to supply the company with injection pens designed to deliver its next-gen obesity ...

Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish ...

The Jefferies London Healthcare Conference at Waldorf Hilton drew thousands, focusing heavily on GLP-1 manufacturing. Notable ...